• Equity PC Ratio   0.57
  • |
  • Index PC Ratio   1.14
  • |
  • Total PC Ratio   0.97
  • |
  • VIX PC Ratio   0.54
  • VIX 12.69
  • VXN 16.04
  • VXO 13.40
  • ISEE 85.00

TruCharts Trading Strategies and Stock Buy/Sell Reports
(Show Details)


Chart Settings
No saved settings found!

Chart Type:
From: / / To: / /
Show detail in :
 Chart Skins:      
Price Overlays:





Indicator Windows:





Company Profile

Trinity Biotech plc acquires, develops, manufactures, distributes, and sells diagnostic test kits and instrumentation worldwide. The company offers clinical laboratory products, including diagnostic tests and instrumentation, which detect infectious diseases, sexually transmitted diseases, and autoimmune disorders. It also sells raw materials to the life sciences industry. In addition, the company offers point of care diagnostic tests, which are carried out in the presence of the patient, principally to diagnose the presence of HIV antibodies in the patient. Its customers include hospitals, clinical laboratories, commercial reference laboratories, and research institutions. Trinity Biotech plc sells its products directly, as well as through distributors and strategic partners. The company was founded in 1992 and is headquartered in Bray, Ireland.

NO
     
TRIB (Trinity Biotech PLC)
Last Trade 0.907 Date 11/12/2019
Change % -2.48 % Price Change -0.03
Open 0.9453 52 Week High 3.99
High 0.97 52 Week Low 0.63
Low 0.907 Type stock
Volume 21812 Average Volume 104323
Prev Close 0.93 Stock Exchange NASDAQ
Bid 0.9053 Ask 0.9505
Bid Size 3 Ask Size 1
1st Yr Estimated EPS Growth 2nd Yr Estimated EPS Growth
2 Years Forward Earning Yield 2 Years Forward PE Ratio
2 Years EV/Forward EBIT 2 Years EV/Forward EBITDA
Book Value per Share 1.8626 Book Value Yield 2.0028
Buy Back Yield CAPE Ratio 1.2683
Cash Return 0.0026 Cash Flow per Share 0.4337
Cash Flow Yield 0.4663 Dividend Rate
Dividend Yield 5 Year Dividend Yield
Earning Yield -1.5186 EV/EBIT
EV/EBITDA EV / Free Cash Flow
EV / Forward EBIT EV / Forward EBITDA
EV / Forward Revenue EV / Pre Tax Income
EV / Revenue 0.8139 EV / Total Asset 0.4399
Expected Dividend Growth Rate Free Cash Flow per Share -0.1623
Free Caash Flow Ratio Free Cash Flow Yield -0.1745
Forward Calculation Style Forward Dividend Yield
Forward Earning Yield Forward PE Ratio
Forward Return on Asset Forward Return on Equity
Normalized PE Ratio Payout Ratio 0.0
PB Ratio 0.499293 PB Ratio 10 Year Growth -0.069255
PB Ratio 3 Year Growth 1.065128 Cash Ratio 3 Year Average 169.8452
Price to Cash Flow Ratio 2.144386 PEG Payback
PEG Ratio PE Ratio
PE Ratio 10 Year Average 25.849738 PE Ratio 10 Year Growth
PE Ratio 10 Year High 70.786123 PE Ratio 10 Year Low 1.699115
PE Ratio 1 Year Avg 30.708238 PE Ratio 1 Year High 33.239858
PE Ratio 1 Year Low 25.985556 PE Ratio 3 Year Avg 45.921446
PE Ratio 5 Year Avg 36.20809 PE Ratio 5 Year High 70.786123
PE Ratio 5 Year Low 17.683524 Free Cash Flow Ratio 10 Year Growth
Free Cash Flow Ratio 3 Year Avg Price Change 1 Month 1.208106
Price to Cash Ratio 0.77475 Price / EBITDA
Price to Sales Ratio 0.251858 Price to Sales Ratio 10 Year Growth 0.043831
Price to Sales Ratio 3 Year Avg 1.174911 Price to Sales Ratio 5 Year Avg 36.20809
Sale per Share 3.6926 Sales Yield 3.9705
Sustainable Growth Rate -0.5522 Tangible Book Value per Share -0.9098
Tangible Book Value per Share 3 year Avg 0.7349 Tangible Book Value per Share 5 year Avg 1.3466
Total Asset per Share 8.2889 Total Yield
Working Capital per Share 2.641 Working Capital per Share 3 Year Avg 4.5984
Working Capital per Share 5 Year Avg 4.4439 Beta 1.487401